Healthy high growth potential
Results
4
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
DONKEY | DKK 8.20 | -3.0% | 30.2% | DKK 344.3m | DKK 9.50 | 166.6 | 99.5% | n/a | Transportation | ||
GUBRA | DKK 300.00 | -14.0% | -25.1% | DKK 5.1b | DKK 501.00 | 18.2 | 106.3% | 0% | Pharmaceuticals & Biotech | ||
BIOPOR | DKK 1.13 | -3.0% | -14.1% | DKK 571.9m | DKK 1.75 | 14.6 | 66.2% | n/a | Pharmaceuticals & Biotech | ||
CBRAIN | DKK 73.40 | 0% | -61.2% | DKK 1.4b | DKK 90.00 | 30.6 | 27.1% | 1.4% | Software |
Page 1 of 1